Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Dry Autumns And Winters May Lead To Fewer Tornadoes In The Spring, Says UGA Researcher
Global warming will likely mean more unpredictable weather, scientists say, and a new study by researchers at the University of Georgia pins down, possibly for the first time, how drought conditions in an area"s fall and winter may effect tornado activity the following spring.
generic viagra online
Healthcare Leader Speaks Out On Latest Hospital "Epidemic"
A global healthcare senior executive has called the latest infection threat to confront the NHS "a national epidemic". Whilst Government statements imply that hospital acquired infections are in decline Jim Taylor, a former Smith & Nephew President and now CEO of infection prevention specialist Saniguard International, says that Norovirus is now an increasing threat to our NHS wards. His company is launching PatientGuard this month - an anti-infection kit created specifically for the UK public, designed to help halt the spread of viruses (including Norovirus & H1N1) & bacteria (including MRSA).
News of the day
Risk Of Heart Failure Doubled By Obesity And Diabetes -- Patients With Both Conditions 'Very Difficult' To Treat
The twin epidemics of obesity and type 2 diabetes will continue to fuel an explosion in heart failure, already the world"s most prevalent chronic cardiovascular disease, according to John McMurray, professor of cardiology at the Western Infirmary, Glasgow, and President of the Heart Failure Association. He reported that around one-third of patients with heart failure have evidence of diabetes, and for them the outlook is very serious. For doctors, he added, effective treatment is "very difficult".
Cardiovascular

House Panel Passes Protection For Drug Makers

The House Energy and Commerce Committee passed an amendment to their broad health reform bill giving drug makers 12 years of exclusive rights to market new biologic drugs, "a setback" to the administration and consumer advocates who hoped to make generic drugs more widely available, the Wall Street Journal reports. The panel voted 47-11 on the measure, which "would also allow "evergreening," the practice by pharmaceutical companies of making minimal adjustments to their drugs, such as creating extended-release versions, as a way to lengthen their monopoly." "Mr. Obama and some Democrats, including the energy committee chairman, Rep. Henry Waxman, D-Calif., have pushed for getting generic versions of complex biologic drugs to the market in five to seven years, saying it would speed up access for consumers to cheaper generic brands and help reduce the country"s health-care costs," the Journal reports (Mundy, 8/1). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009